帕博利珠单抗联合二甲双胍治疗转移性头颈部癌的 II 期可行性研究
A Phase II Feasibility Study Combining Pembrolizumab and Metformin in Patients with Metastatic Head and Neck Cancer.
二甲双胍联合帕博利珠单抗耐受性良好,仅出现轻度胃肠道不良事件,并展现出有前景的活性,值得在随机试验中进一步研究。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Fibroblast activation protein (FAP) as a prognostic biomarker in multiple tumors and its therapeutic potential in head and neck squamous cell carcinoma.
Fibroblast activation protein (FAP) as a prognostic biomarker in multiple tumors and its therapeutic potential in head and neck squamous cell carcinoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们的研究揭示了 FAP 与多种癌症不良肿瘤预后之间的关联,并强调了其作为 HNSC 治疗靶点的潜力。
成纤维细胞激活蛋白(FAP)是一种细胞表面丝氨酸蛋白酶,在肿瘤侵袭和免疫调节中发挥作用。然而,目前尚无FAP的泛癌分析。目的:我们旨在评估FAP的泛癌表达谱、其分子功能及其在头颈部鳞状细胞癌(HNSC)中的潜在作用。
我们分析了FAP在癌症基因组图谱(TCGA)和基因型组织表达(GTEx)肿瘤中的基因表达、生存状态、免疫浸润和分子功能通路。此外,为阐明FAP在HNSC中的作用,我们在FAP过表达或敲低后进行了增殖、迁移和侵袭实验。
FAP 在九种肿瘤类型中表达升高,并与其中八种肿瘤类型的不良生存相关。在免疫浸润方面,FAP 表达在五种肿瘤类型中与 CD8+ T 细胞浸润呈负相关,在四种肿瘤类型中与调节性 T 细胞浸润呈正相关。我们的富集分析突显了 FAP 参与 PI3K-Akt 信号通路。在 HNSC 细胞中,FAP 过表达激活了 PI3K-Akt 通路,促进肿瘤增殖、迁移和侵袭。相反,FAP 敲低显示出抑制作用。
Fibroblast activation protein (FAP), a cell surface serine protease, plays roles in tumor invasion and immune regulation. However, there is currently no pan-cancer analysis of FAP. Objective: We aimed to assess the pan-cancer expression profile of FAP, its molecular function, and its potential role in head and neck squamous cell carcinoma (HNSC).
We analyzed gene expression, survival status, immune infiltration, and molecular functional pathways of FAP in The Cancer Genome Atlas (TCGA) and Genotype Tissue Expression (GTEx) tumors. Furthermore, to elucidate the role of FAP in HNSC, we performed proliferation, migration, and invasion assays post-FAP overexpression or knock-down.
FAP expression was elevated in nine tumor types and was associated with poor survival in eight of them. In the context of immune infiltration, FAP expression negatively correlated with CD8+ T-cell infiltration in five tumor types and positively with regulatory T-cell infiltration in four tumor types. Our enrichment analysis highlighted FAP's involvement in the PI3K-Akt signaling pathway. In HNSC cells, FAP overexpression activated the PI3K-Akt pathway, promoting tumor proliferation, migration, and invasion. Conversely, FAP knockdown showed inhibitory effects.
Our study unveils the association of FAP with poor tumor prognosis across multiple cancers and highlights its potential as a therapeutic target in HNSC.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。